Abstract
Previously, we identified 3 overlapping regions showing loss of heterozygosity (LOH, R1–R3 from 11 to 30 cM) on chromosome 17 in 45 primary gastric cancers (GCs). The data indicated the presence of tumor suppressor genes (TSGs) on chromosome 17 involved in GC. Among the putative TSGs in these regions, HIC1 (in SR1) and TOB1 (in SR3) remain to be examined in GC. By immunohistochemistry (IHC), methylation-specific PCR (MSP) and western blot, we evaluated the expression and regulation status for HIC1 and TOB1 protein in GC. We narrowed down the deletion intervals on chromosome 17 and defined five smaller LOH subregions, SR1–SR5 (0.54 to 3.42 cM), in GC. We found that HIC1 had downregulated expression in 86% (91/106) and was methylated in 87% (26/30) of primary GCs. Of the primary GCs showing downregulation of HIC1 protein, 75% (18/24) had methylated HIC1 gene. TOB1 was either absent or expressed at reduced levels in 75% (73/97) of the GC samples. In addition, a general reduction was found in total and the ratio of unphosphorylated to phosphorylated TOB1 protein levels in the differentiated GC cell lines. Further analysis revealed significant simultaneous downregulation of both HIC1 and TOB1 protein in GC tissue microarray samples (67%, 52/78) and in primary GCs (65%, 11/17). These results indicate that silencing of HIC1 and TOB1 expression is a common occurrence in GC and may contribute to the development and progression of the disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahuja, N., Mohan, A.L., Li, Q., Stolker, J.M., Herman, J.G., Hamilton, S.R., Baylin, S.B., and Issa, J.P. (1997). Association between cpg island methylation and microsatellite instability in colorectal cancer. Cancer Res. 57, 3370–3374.
Dockhorn-Dworniczak, B., Poremba, C., Dantcheva, R., Stucker, A., Brommelkamp, E., Blasius, S., Mellin, W., Roessner, A., Yandell, D.W., and Bocker, W. (1994). Rapid detection of loss of heterozygosity of chromosome 17p by polymerase chain reaction-based variable number of tandem repeat analysis and detection of single-strand conformation polymorphism of intragenic p53 polymorphisms. Virchows Arch. 424, 337–342.
Dong, S.M., Kim, H.S., Rha, S.H., and Sidransky, D. (2001). Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin. Cancer Res. 7, 1982–1986.
Feng, Q., Deftereos, G., Hawes, S.E., Stern, J.E., Willner, J.B., Swisher, E.M., Xi, L., Drescher, C., Urban, N., and Kiviat, N. (2008). DNA hypermethylation, her-2/neu overexpression and p53 mutations in ovarian carcinoma. Gynecol. Oncol. 111, 320–329.
Fong, K.M., Kida, Y., Zimmerman, P.V., Ikenaga, M., and Smith, P.J. (1995). Loss of heterozygosity frequently affects chromosome 17q in non-small cell lung cancer. Cancer Res. 55, 4268–4272.
Fujii, H., Biel, M.A., Zhou, W., Weitzman, S.A., Baylin, S.B., and Gabrielson, E. (1998). Methylation of the hic-1 candidate tumor suppressor gene in human breast cancer. Oncogene 16, 2159–2164.
Hayashi, M., Tokuchi, Y., Hashimoto, T., Hayashi, S., Nishida, K., Ishikawa, Y., Nakagawa, K., Tsuchiya, S., Okumura, S., and Tsuchiya, E. (2001). Reduced hic-1 gene expression in non-small cell lung cancer and its clinical significance. Anticancer Res. 21, 535–540.
Herman, J.G., and Baylin, S.B. (2003). Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349, 2042–2054.
Herman, J.G., Graff, J.R., Myohanen, S., Nelkin, B.D., and Baylin, S.B. (1996). Methylation-specific pcr: A novel pcr assay for methylation status of cpg islands. Proc. Natl. Acad. Sci. USA 93, 9821–9826.
Ito, Y., Suzuki, T., Yoshida, H., Tomoda, C., Uruno, T., Takamura, Y., Miya, A., Kobayashi, K., Matsuzuka, F., Kuma, K., et al. (2005). Phosphorylation and inactivation of tob contributes to the progression of papillary carcinoma of the thyroid. Cancer Lett. 220, 237–242.
Iwanaga, K., Sueoka, N., Sato, A., Sakuragi, T., Sakao, Y., Tominaga, M., Suzuki, T., Yoshida, Y., K-Tsuzuku, J., Yamamoto, T., et al. (2003). Alteration of expression or phosphorylation status of tob, a novel tumor suppressor gene product, is an early event in lung cancer. Cancer Lett. 202, 71–79.
Kanai, Y., Hui, A.M., Sun, L., Ushijima, S., Sakamoto, M., Tsuda, H., and Hirohashi, S. (1999). DNA hypermethylation at the d17s5 locus and reduced hic-1 mrna expression are associated with hepatocarcinogenesis. Hepatology 29, 703–709.
Klebig, C., Seitz, S., Korsching, E., Kristiansen, G., Gustavus, D., Scherneck, S., and Petersen, I. (2005). Profile of differentially expressed genes after transfer of chromosome 17 into the breast cancer cell line cal51. Genes Chromosomes Cancer 44, 233–246.
Knudson, A.G. (2002). Cancer genetics. Am. J. Med. Genet 111, 96–102.
Melki, J.R., Vincent, P.C., and Clark, S.J. (1999). Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res. 59, 3730–3740.
Noguchi, T., Wirtz, H.C., Michaelis, S., Gabbert, H.E., and Mueller, W. (2001). Chromosomal imbalances in gastric cancer. Correlation with histologic subtypes and tumor progression. Am. J. Clin. Pathol. 115, 828–834.
Park, G.T., Seo, E.Y., Lee, K.M., Lee, D.Y., and Yang, J.M. (2006). Tob is a potential marker gene for the basal layer of the epidermis and is stably expressed in human primary keratinocytes. Br. J. Dermatol. 154, 411–418.
Petty, E.M., Kalikin, L.M., Orringer, M.B., and Beer, D.G. (1998). Distal chromosome 17q loss in barrett’s esophageal and gastric cardia adenocarcinomas: Implications for tumorigenesis. Mol. Carcinog. 22, 222–228.
Rood, B.R., Zhang, H., Weitman, D.M., and Cogen, P.H. (2002). Hypermethylation of hic-1 and 17p allelic loss in medulloblastoma. Cancer Res. 62, 3794–3797.
Russell, S.E., McIlhatton, M.A., Burrows, J.F., Donaghy, P.G., Chanduloy, S., Petty, E.M., Kalikin, L.M., Church, S.W., McIlroy, S., Harkin, D.P., et al. (2000). Isolation and mapping of a human septin gene to a region on chromosome 17q, commonly deleted in sporadic epithelial ovarian tumors. Cancer Res. 60, 4729–4734.
Semba, S., Yokozaki, H., Yasui, W., and Tahara, E. (1998). Frequent microsatellite instability and loss of heterozygosity in the region including brca1 (17q21) in young patients with gastric cancer. Int. J. Oncol. 12, 1245–1251.
Suzuki, T., Matsuda, S., Tsuzuku, J.K., Yoshida, Y., and Yamamoto, T. (2001). A serine/threonine kinase p90rsk1 phosphorylates the anti-proliferative protein tob. Genes Cells 6, 131–138.
Tahara, E. (2004). Genetic pathways of two types of gastric cancer. IARC Sci. Publ. 327-349.
Tamura, G. (2002). Genetic and epigenetic alterations of tumor suppressor and tumor-related genes in gastric cancer. Histol. Histopathol. 17, 323–329.
Tamura, G. (2004). Promoter methylation status of tumor suppressor and tumor-related genes in neoplastic and non-neoplastic gastric epithelia. Histol. Histopathol. 19, 221–228.
Tokumaru, Y., Nomoto, S., Jeronimo, C., Henrique, R., Harden, S., Trink, B., and Sidransky, D. (2003). Biallelic inactivation of the riz1 gene in human gastric cancer. Oncogene 22, 6954–6958.
Wang, D., Fang, D., and Lou, Y. (1997). A study on the loss of heterozygosity at 17p13.3 and abnormal expression of p53 protein in gastric carcinoma. Zhonghua Bing Li Xue Za Zhi 26, 134–136.
Wales, M.M., Biel, M.A., el Deiry, W., Nelkin, B.D., Issa, J.P., Cavenee, W.K., Kuerbitz, S.J., and Baylin, S.B. (1995). P53 activates expression of hic-1, a new candidate tumour suppressor gene on 17p13.3. Nat. Med. 1, 570–577.
Yamanaka, M., Watanabe, M., Yamada, Y., Takagi, A., Murata, T., Takahashi, H., Suzuki, H., Ito, H., Tsukino, H., Katoh, T., et al. (2003). Altered methylation of multiple genes in carcinogenesis of the prostate. Int. J. Cancer 106, 382–387.
Yoshida, Y., Nakamura, T., Komoda, M., Satoh, H., Suzuki, T., Tsuzuku, J.K., Miyasaka, T., Yoshida, E.H., Umemori, H., Kunisaki, R.K., et al. (2003). Mice lacking a transcriptional corepressor tob are predisposed to cancer. Genes Dev. 17, 1201–1206.
Yu, J., Zhou, H., Jin, Y., Bai, J., Yu, Y., Geng, J., Qi, J., and Fu, S. (2008). Three distinct regions of allelic deletion on chromosome 17 involved in sporadic gastric cancer. Hepatogastroenterology 55, 1487–1491.
Yu, J.C., Zhou, H., Bai, J., Yu, Y., Geng, J.S., Qi, J.P., and Fu, S.B. (2008). Human gastric adenocarcinoma allelotype on chromosomes 17 and 18. J. Int. Med. Res. 36, 279–288.
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this work.
About this article
Cite this article
Yu, J., Liu, P., Cui, X. et al. Identification of novel subregions of LOH in gastric cancer and analysis of the HIC1 and TOB1 tumor suppressor genes in these subregions. Mol Cells 32, 47–55 (2011). https://doi.org/10.1007/s10059-011-2316-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10059-011-2316-4